These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8129189

  • 1. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Neirotti M, Molaschi M, Ponzetto M, Macchione C, Poli L, Bonino F, Fabris F.
    Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
    [Abstract] [Full Text] [Related]

  • 2. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V, Ammaturo V, Guarini P, Tedeschi C, Nunziata G, Nappi A, Forgione L, Rengo F.
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of picotamide in long-term treatment of intermittent claudication.
    Coto V, Cocozza M, Oliviero U, Lucariello A, Picano T, Coto F, Cacciatore L.
    Angiology; 1989 Oct; 40(10):880-5. PubMed ID: 2679241
    [Abstract] [Full Text] [Related]

  • 4. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
    Milani M, Longoni A, Maderna M.
    Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
    [Abstract] [Full Text] [Related]

  • 5. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Dec; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of arteriolar reactivity and blood coagulation parameters during picotamide treatment].
    Saitta A, Bonaiuto M, Mileto A.
    Clin Ter; 2002 Dec; 139(1-2):9-16. PubMed ID: 1837769
    [Abstract] [Full Text] [Related]

  • 7. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 8. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG, Coccheri S, Marubini E, Violi F, Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics (DAVID) Study Group.
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [Abstract] [Full Text] [Related]

  • 9. Effects of prolonged picotamide therapy on platelet activity in patients with peripheral arterial disease.
    Danese C, Sergio G, Giunta G, Landi MT, Renzulli C, Panciocco MG, De Rossi MG, Perego MA.
    Curr Med Res Opin; 1988 Oct; 11(4):221-6. PubMed ID: 2975203
    [Abstract] [Full Text] [Related]

  • 10. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
    Craveri A, Colombo L, Cristina M, Coloru M, De Angeli B, Lanfredini M.
    Clin Ter; 1991 Jan 15; 136(1):23-9. PubMed ID: 1826869
    [Abstract] [Full Text] [Related]

  • 11. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E.
    Kardiol Pol; 2003 Sep 15; 59(9):197-204. PubMed ID: 14618196
    [Abstract] [Full Text] [Related]

  • 12. A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease.
    Pasqualini L, Pirro M, Lombardini R, Ciuffetti G, Dragani P, Mannarino E.
    J Clin Pathol; 2002 Dec 15; 55(12):946-50. PubMed ID: 12461065
    [Abstract] [Full Text] [Related]

  • 13. [Antiplatelet activity of picotamide in patients with chronic vascular pathology].
    Coto V, Carrieri P, Cocozza M, Oliviero U, Picano T, Spinoli G, Cacciatore L.
    Minerva Cardioangiol; 1986 Sep 15; 34(9):601-4. PubMed ID: 2949164
    [No Abstract] [Full Text] [Related]

  • 14. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
    Hiatt WR, Krantz MJ.
    Vasc Med; 2006 Feb 15; 11(1):55-60. PubMed ID: 16669416
    [Abstract] [Full Text] [Related]

  • 15. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
    Cocozza M, Milani M, Picano T, Oliviero U, Russo N, Coto V.
    Vasc Med; 1997 Nov 15; 2(4):292-5. PubMed ID: 9575601
    [Abstract] [Full Text] [Related]

  • 16. Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patients.
    Cocozza M, Picano T, Oliviero U, Russo N, Coto V, Milani M.
    Stroke; 1995 Apr 15; 26(4):597-601. PubMed ID: 7709404
    [Abstract] [Full Text] [Related]

  • 17. [Clinical study of picotamide in patients with vascular diseases].
    Speziale F, Taurino M, Colella E, Rizzo L, Fiorani P.
    Recenti Prog Med; 1989 May 15; 80(5):271-5. PubMed ID: 2762664
    [Abstract] [Full Text] [Related]

  • 18. Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
    Gresele P, Migliacci R.
    Eur Heart J; 2004 Oct 15; 25(20):1769-71. PubMed ID: 15474690
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 15; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 20. Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
    Blardi P, de Lalla A, Pieragalli D, De Franco V, Meini S, Ceccatelli L, Auteri A.
    Prostaglandins Other Lipid Mediat; 2006 Sep 15; 80(3-4):175-82. PubMed ID: 16939882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.